Welcome to the InfoSci Platform
Reference Hub1
Dysbiosis, Small Intestinal Bacterial Overgrowth, and Chronic Diseases: A Translational Approach

Dysbiosis, Small Intestinal Bacterial Overgrowth, and Chronic Diseases: A Translational Approach

Ana Rita Silva, Maria Alexandra Bernardo, Maria Fernanda Mesquita, José Vaz Patto, Pedro Moreira, Patrícia Padrão, Maria Leonor Silva
Copyright: © 2021 |Pages: 29
ISBN13: 9781799848080|ISBN10: 1799848086|EISBN13: 9781799848097
DOI: 10.4018/978-1-7998-4808-0.ch015
Cite Chapter Cite Chapter

MLA

Silva, Ana Rita, et al. "Dysbiosis, Small Intestinal Bacterial Overgrowth, and Chronic Diseases: A Translational Approach." Treating Endocrine and Metabolic Disorders With Herbal Medicines, edited by Arif Hussain and Shalini Behl, IGI Global, 2021, pp. 334-362. https://doi.org/10.4018/978-1-7998-4808-0.ch015

APA

Silva, A. R., Bernardo, M. A., Mesquita, M. F., Vaz Patto, J., Moreira, P., Padrão, P., & Silva, M. L. (2021). Dysbiosis, Small Intestinal Bacterial Overgrowth, and Chronic Diseases: A Translational Approach. In A. Hussain & S. Behl (Eds.), Treating Endocrine and Metabolic Disorders With Herbal Medicines (pp. 334-362). IGI Global. https://doi.org/10.4018/978-1-7998-4808-0.ch015

Chicago

Silva, Ana Rita, et al. "Dysbiosis, Small Intestinal Bacterial Overgrowth, and Chronic Diseases: A Translational Approach." In Treating Endocrine and Metabolic Disorders With Herbal Medicines, edited by Arif Hussain and Shalini Behl, 334-362. Hershey, PA: IGI Global, 2021. https://doi.org/10.4018/978-1-7998-4808-0.ch015

Export Reference

Mendeley
Favorite

Abstract

Dysbiosis is characterized by an alteration in quantity and quality of intestinal microbiota composition. In the presence of dysbiosis, enterocytes will have difficulty in maintaining the integrity of the mucosal barrier, leading to increased intestinal permeability. These events are recognised to be linked to several chronic diseases. One of the consequences of dysbiosis is the manifestation of small intestinal bacterial overgrowth (SIBO), which is associated to a variety of chronic diseases. Single food nutrients and bioactive molecules, food additives, pre- and probiotics, and different dietary patterns may change the composition of the intestinal microbiota. Low FODMAPs diet has been a reference in SIBO treatment. This chapter intends to describe how the intestinal microbiota, dysbiosis, and SIBO can be related; to define dysbiosis food and nutrients influence; and to offer some nutritional therapy strategies for applying the low FODMAPs protocol, enabling better adherence by patients in order to increase their wellbeing.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.